Season 2 · Episode 22
S2 Ep22: Between the Lines™ Podcast: Mobocertinib Use in Platinum-Pretreated Patients With EGFR Exon 20 Insertion–Positive mNSCLC
April 27, 202227m 37s
Audio is streamed directly from the publisher (audioboom.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
OncView™ Podcast: Mobocertinib Use in Platinum-Pretreated Patients With EGFR Exon 20 Insertion–Positive mNSCLC
As part of its OncView™ video series, CancerNetwork® spoke with Gregory Riely, MD, PhD, vice chair of Clinical Research in the Department of Medicine at Memorial Sloan Kettering Cancer Center in New York, and Tarek Mekhail, MD, a hematologic oncologist from Advent Health in Florida, about patients with EGFR exon 20 insertion-positive metastatic non–small cell lung cancer who recieved mobocertinib.
In the video series, Gregory Riely, MD, PhD, and Tarek Mekhail, MD, discussed the following:
As part of its OncView™ video series, CancerNetwork® spoke with Gregory Riely, MD, PhD, vice chair of Clinical Research in the Department of Medicine at Memorial Sloan Kettering Cancer Center in New York, and Tarek Mekhail, MD, a hematologic oncologist from Advent Health in Florida, about patients with EGFR exon 20 insertion-positive metastatic non–small cell lung cancer who recieved mobocertinib.
In the video series, Gregory Riely, MD, PhD, and Tarek Mekhail, MD, discussed the following:
- Mobocertinib Use in mNSCLC: EXCLAIM Cohort Study Design
- Efficacy Data From the EXCLAIM Cohort in mNSCLC
- EXCLAIM Cohort: Mobocertinib Safety Data in mNSCLC
- EXCLAIM Cohort in mNSCLC: Treatment Selection and Management
- mNSCLC: Biomarker Testing and Patient Adherence to TKIs
- Next Steps in the Management of EGFR Exon 20 Insertion–Positive mNSCLC
To watch more videos in CancerNetwork®’s OncView™ series, visit cancernetwork.com/oncview.